Condition
Stage IIIC Ovarian Cancer AJCC v8 clinical trials and research
Research outlook What's coming for Ovarian cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Stage IIIC Ovarian Cancer AJCC v8 clinical trials that are recruiting, at sites in 5 countries (most in United States (4), Canada (1), Italy (1)). By phase: Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Stage IIIC Ovarian Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Treatment of advanced solid tumors with IACS-6274 and other medications | Phase 1 | Houston, Texas | Recruiting | Sep 10, 2021 |
| Using a uterine wash and a blood protein test to find ovarian cancer early | — | Little Rock, Arkansas and 5 other locations | Recruiting | Mar 12, 2021 |
| Minimally invasive surgery for advanced ovarian cancer after chemotherapy | Phase 3 | Miami, Florida and 18 other locations | Recruiting | Oct 5, 2020 |
All recruiting trials (4)
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Treatment of advanced solid tumors with IACS-6274 and other medications
This study is testing a new drug called IACS-6274, alone and with other medications, to see how well it can help people with advanced solid tumors and what the safest dose is.
-
Using a uterine wash and a blood protein test to find ovarian cancer early
This project will try to find tumor DNA in a uterine wash plus protein markers in blood to detect ovarian or fallopian tube cancer in women having surgery for a suspected ovarian growth or BRCA1/2 carriers having risk-reducing surgery.
-
Minimally invasive surgery for advanced ovarian cancer after chemotherapy
This study is testing if a less invasive surgery is just as effective as traditional surgery for women with advanced ovarian cancer after they have had chemotherapy.
Related topics
Quick answers
How many Stage IIIC Ovarian Cancer AJCC v8 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Canada (1 trial), Italy (1 trial), Mexico (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.